Tanhaji, Gina S.

HRN: 21-87-28  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/01/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
09/01/2022
09/08/2022
IV
500mg
Q8h
Acute Gastroenteritis
Waiting Final Action 
09/01/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/01/2022
09/08/2022
IV
500mg
Q8h
Acute Gastroenteritis
Waiting Final Action 
09/02/2022
METRONIDAZOLE 500MG (TAB)
09/02/2022
09/09/2022
PO
500 Mg
TID
AGE WITH NO DEHYDRATION
Waiting Final Action 
09/02/2022
CEFUROXIME 500MG (TAB)
09/02/2022
09/09/2022
PO
500 Mg
TID
AGE WITH MOD DEHYDRATION
Waiting Final Action 
09/02/2022
CEFUROXIME 500MG (TAB)
09/02/2022
09/09/2022
ORAL
1 Cap
BID
S/P NSVD
Waiting Final Action 
09/02/2022
METRONIDAZOLE 500MG (TAB)
09/02/2022
09/09/2022
ORAL
1 Tab
BID
AGE

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: